MARY DUONG: Open Payments
NPI 1386607638 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,065 in 19 payments from 6 companies in 2025. Trend: 2023 $806 · 2024 $1,358 · 2025 $2,065
Consulting: $1,325Food & beverage: $641Education: $99
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $1,325 |
| PFIZER INC. | 6 | $364 |
| Janssen Biotech, Inc. | 5 | $195 |
| SEAGEN INC. | 1 | $99 |
| Merck Sharp & Dohme LLC | 2 | $62 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: Nubeqa, PADCEV, ERLEADA, TALZENNA, KEYTRUDA, XTANDI, RYBREVANT, LYNPARZA.
Industry payments across CA — which companies pay providers there.
